TENET HEALTHCARE CORP Income (Loss), Including Portion Attributable to Noncontrolling Interest, before Tax
TENET HEALTHCARE CORP (THC) reported Income (Loss), Including Portion Attributable to Noncontrolling Interest, before Tax of $1.34 billion for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:IncomeLossIncludingPortionAttributableToNoncontrollingInterest · last filed 2026-07-29
- TENET HEALTHCARE CORP income (loss), including portion attributable to noncontrolling interest, before tax for the quarter ending 2026-06-30 was $1.34B, a 108.72% increase year-over-year.
- TENET HEALTHCARE CORP income (loss), including portion attributable to noncontrolling interest, before tax for the quarter ending 2026-03-31 was $1.13B, a 47.97% increase year-over-year.
- TENET HEALTHCARE CORP income (loss), including portion attributable to noncontrolling interest, before tax for the quarter ending 2025-12-31 was $681.00M, a 3.97% increase year-over-year.
- TENET HEALTHCARE CORP income (loss), including portion attributable to noncontrolling interest, before tax for the quarter ending 2025-09-30 was $712.00M, a 22.78% decline year-over-year.
- TENET HEALTHCARE CORP income (loss), including portion attributable to noncontrolling interest, before tax for fiscal 2025 was $2.80B, a 46.65% decline from fiscal 2024.
- TENET HEALTHCARE CORP income (loss), including portion attributable to noncontrolling interest, before tax for fiscal 2024 was $5.25B, a 224.55% increase from fiscal 2023.
- TENET HEALTHCARE CORP income (loss), including portion attributable to noncontrolling interest, before tax for fiscal 2023 was $1.62B, a 20.22% increase from fiscal 2022.
- TENET HEALTHCARE CORP income (loss), including portion attributable to noncontrolling interest, before tax for fiscal 2022 was $1.34B.
| Period end | Income (Loss), Including Portion Attributable to Noncontrolling Interest, before Tax 3 month | Income (Loss), Including Portion Attributable to Noncontrolling Interest, before Tax 6 month | Income (Loss), Including Portion Attributable to Noncontrolling Interest, before Tax 9 month | Income (Loss), Including Portion Attributable to Noncontrolling Interest, before Tax 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.34B 10-Q · filed 2026-07-29 | $2.47B 10-Q · filed 2026-07-29 | $3.15B derived: sum of 3 quarters · filed 2026-07-29 | $3.87B derived: sum of 4 quarters · filed 2026-07-29 |
| 2026-03-31 | $1.13B 10-Q · filed 2026-04-30 | $1.81B derived: sum of 2 quarters · filed 2026-04-30 | $2.52B derived: sum of 3 quarters · filed 2026-04-30 | $3.17B derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-12-31 | $681.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $1.39B derived: sum of 2 quarters · filed 2026-02-17 | $2.04B derived: sum of 3 quarters · filed 2026-07-29 | $2.80B 10-K · filed 2026-02-17 |
| 2025-09-30 | $712.00M 10-Q · filed 2025-10-28 | $1.35B derived: sum of 2 quarters · filed 2026-07-29 | $2.12B 10-Q · filed 2025-10-28 | $2.77B derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-06-30 | $642.00M 10-Q · filed 2026-07-29 | $1.41B 10-Q · filed 2026-07-29 | $2.06B derived: sum of 3 quarters · filed 2026-07-29 | $2.98B derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-03-31 | $765.00M 10-Q · filed 2026-04-30 | $1.42B derived: sum of 2 quarters · filed 2026-04-30 | $2.34B derived: sum of 3 quarters · filed 2026-04-30 | $2.93B derived: sum of 4 quarters · filed 2026-04-30 |
| 2024-12-31 | $655.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $1.58B derived: sum of 2 quarters · filed 2026-02-17 | $2.16B derived: sum of 3 quarters · filed 2026-02-17 | $5.25B 10-K · filed 2026-02-17 |
| 2024-09-30 | $922.00M 10-Q · filed 2025-10-28 | $1.51B derived: sum of 2 quarters · filed 2025-10-28 | $4.59B 10-Q · filed 2025-10-28 | $5.11B derived: sum of 4 quarters · filed 2026-02-17 |
| 2024-06-30 | $587.00M 10-Q · filed 2025-07-30 | $3.67B 10-Q · filed 2025-07-30 | $4.19B derived: sum of 3 quarters · filed 2026-02-17 | $4.54B derived: sum of 4 quarters · filed 2026-02-17 |
| 2024-03-31 | $3.08B 10-Q · filed 2025-04-29 | $3.60B derived: sum of 2 quarters · filed 2026-02-17 | $3.95B derived: sum of 3 quarters · filed 2026-02-17 | $4.32B derived: sum of 4 quarters · filed 2026-02-17 |
| 2023-12-31 | $519.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $864.00M derived: sum of 2 quarters · filed 2026-02-17 | $1.24B derived: sum of 3 quarters · filed 2026-02-17 | $1.62B 10-K · filed 2026-02-17 |
| 2023-09-30 | $345.00M 10-Q · filed 2024-10-29 | $718.00M derived: sum of 2 quarters · filed 2024-10-29 | $1.10B 10-Q · filed 2024-10-29 | |
| 2023-06-30 | $373.00M 10-Q · filed 2024-07-30 | $753.00M 10-Q · filed 2024-07-30 | ||
| 2023-03-31 | $380.00M 10-Q · filed 2024-04-30 | |||
| 2022-12-31 | $1.34B 10-K · filed 2025-02-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Surgery Partners, Inc. (SGRY) | United States | $1.860B | -24.80 |
| Ardent Health, Inc. (ARDT) | United States | $1.478B | 17.91 |
| COMMUNITY HEALTH SYSTEMS INC (CYH) | United States | $0.405B | 1.87 |
| HCA Healthcare, Inc. (HCA) | United States | $93.934B | 15.49 |